HCPCS code J1552 — Inj, alyglo, 500 mg. Status: Active. Effective Jan 1, 2025. Source: CMS HCPCS Level II.

J1552

Active

Inj, alyglo, 500 mg

Injection, immune globulin (alyglo), 500 mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Jan 1, 2025
Code type: alphanumeric
OPPS Status: K — Non-pass-through drugs and biologicals
OPPS APC: 0819

MUE — Medically Unlikely Edits

Maximum units of J1552 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
DME Supplier 1200
Outpatient Hospital 1200
Practitioner Services 1200

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
61476-0104-05 Alyglo
61476-0104-10 Alyglo
61476-0104-20 Alyglo

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2025-Q1
    Inj, alyglo, 500 mg